HC Wainwright Issues Positive Estimate for RYTM Earnings
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) - Investment analysts at HC Wainwright increased their Q1 2025 earnings estimates for shares of Rhythm Pharmaceuticals in a note issued to investors on Monday, March 3rd. HC Wainwright analyst R. Selvaraju now forecasts that the company wil.
Publicado el: 2025-03-07 12:03:18
Autor: lulegacy, Fuente: lulegacy
Compartir: 
